Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategies.
Wang Y, Quan Q, Gleason C, Yu H, Peng L, Kang Y, Jiang L, Wu K, Pan J, Bao M, Zhu Q, Yi M, Fang M, Zheng Y, Qiu L, Xu B, Li X, Song J, Sun J, Zhang Z, Su Z, Lin J, Xie Y, Xu A, Song X, Huang C, Shen Z, Wang L, Song J.
Wang Y, et al. Among authors: quan q.
MAbs. 2023 Jan-Dec;15(1):2292305. doi: 10.1080/19420862.2023.2292305. Epub 2023 Dec 14.
MAbs. 2023.
PMID: 38095560
Free PMC article.